How to Buy Astec Lifesciences Ltd Shares?
You can easily buy the stocks/shares of Astec Lifesciences Ltd (ASTEC) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Astec Lifesciences Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ASTEC as on 15th May 2025 is ₹689.25What is the return on Astec Lifesciences Ltd share?
The past returns of Astec Lifesciences Ltd (ASTEC) share are- Past 1 week: N/A
- Past 1 month: -84.37
- Past 3 months: 20.65
- Past 6 months: -27.09
- Past 1 year: -35.97
- Past 3 years: -54.88
- Past 5 years: 11.96
What is the Dividend yield % on Astec Lifesciences Ltd share?
The current dividend yield of Astec Lifesciences Ltd (ASTEC) is N/AWhat is the Market Cap of Astec Lifesciences Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astec Lifesciences Ltd (ASTEC) is ₹1545.12Cr as of 15th May 2025What is the 52 Week High and Low of Astec Lifesciences Ltd?
The 52-week high and low of Astec Lifesciences Ltd (ASTEC) is ₹1474.40 and ₹634.60.What is the PE and PB ratio of Astec Lifesciences Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Astec Lifesciences Ltd are -11.47 and 4.18 respectively.Which sector does Astec Lifesciences Ltd belong to?
Astec Lifesciences Ltd (ASTEC) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.What are the peers or stocks similar to Astec Lifesciences Ltd?
The peers or stocks similar to Astec Lifesciences Ltd are: and many others.Can't decide whether or not to buy Astec Lifesciences Ltd?
Worry no more! Login to Tickertape and check out Astec Lifesciences Ltd (ASTEC) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Astec Lifesciences Ltd?
The 52-week high and low of Astec Lifesciences Ltd (ASTEC) is ₹1474.40 and ₹634.60.1. Test Stocks FAQ for Astec Lifesciences Ltd Shares?
You can easily buy the stocks/shares of Astec Lifesciences Ltd (ASTEC) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Astec Lifesciences Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ASTEC as on 15th May 2025 is ₹689.25
Astec Lifesciences Ltd
ASTEC Share Price
689.250.61% (+4.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
ASTEC Performance & Key Metrics
ASTEC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -11.47 | 4.18 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.21 | 3.46 | 1.60% |
ASTEC Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ASTEC Company Profile
Astec LifeSciences Limited is a holding company. The Company is a producer of agrochemicals and pharmaceutical intermediates.
COROMANDEL
PE Ratio
32.65
32.65
1Y Return
52.93%
52.93%
Buy Reco %
90.91
90.91
PE Ratio
1,591.48
1,591.48
1Y Return
31.46%
31.46%
Buy Reco %
—
—
UPL
PE Ratio
63.67
63.67
1Y Return
18.23%
18.23%
Buy Reco %
96.15
96.15
BAYERCROP
PE Ratio
43.07
43.07
1Y Return
11.14%
11.14%
Buy Reco %
55.56
55.56
CHAMBLFERT
PE Ratio
13.33
13.33
1Y Return
26.35%
26.35%
Buy Reco %
100.00
100.00
ASTEC Sentiment Analysis
ASTEC Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ASTEC Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
ASTEC Stock Growth Drivers
ASTEC Stock Growth Drivers
0
Hmm, looks like there are nogrowth drivers
ASTEC Stock Challenges
ASTEC Stock Challenges
4Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
ASTEC Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
ASTEC Forecasts
Price
Revenue
Earnings
ASTEC Share Price Forecast
ASTEC Share Price Forecast
2025
Current
₹788.90
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹788.90
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTEC Company Revenue Forecast
ASTEC Company Revenue Forecast
2025
Current
₹386.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹386.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ASTEC Stock EPS (Earnings Per Share) Forecast
ASTEC Stock EPS (Earnings Per Share) Forecast
2025
Current
₹-68.71
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹-68.71
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTEC
ASTEC
Income
Balance Sheet
Cash Flow
Annual Normal View
ASTEC Income Statement
ASTEC Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 301.53 | 395.02 | 442.06 | 534.54 | 562.79 | 687.04 | 641.23 | 463.82 | 386.93 | 386.93 | ||||||||||
Raw Materials | 179.66 | 224.22 | 295.05 | 333.81 | 344.60 | 444.82 | 460.83 | 318.82 | 447.51 | 447.51 | ||||||||||
| Power & Fuel Cost | 15.75 | 17.87 | 23.80 | 28.80 | 25.28 | 38.04 | 45.68 | 35.87 | ||||||||||||
| Employee Cost | 20.38 | 21.71 | 25.10 | 29.92 | 38.35 | 50.31 | 52.26 | 61.74 | ||||||||||||
| Selling & Administrative Expenses | 13.65 | 16.74 | 15.41 | 21.83 | 17.17 | 23.55 | 25.77 | 20.97 | ||||||||||||
| Operating & Other expenses | 17.44 | 33.43 | -4.93 | 23.07 | 17.92 | -34.22 | -32.63 | 26.69 | ||||||||||||
EBITDA | 54.65 | 81.05 | 87.63 | 97.11 | 119.47 | 164.54 | 89.32 | -0.27 | -60.58 | -60.58 | ||||||||||
| Depreciation/Amortization | 13.68 | 14.68 | 19.35 | 23.16 | 25.66 | 34.36 | 33.65 | 36.25 | 43.71 | 43.72 | ||||||||||
| PBIT | 40.97 | 66.37 | 68.28 | 73.95 | 93.81 | 130.18 | 55.67 | -36.52 | -104.29 | -104.30 | ||||||||||
| Interest & Other Items | 12.24 | 10.66 | 12.38 | 12.59 | 4.75 | 9.06 | 20.71 | 25.23 | 36.70 | 36.69 | ||||||||||
| PBT | 28.73 | 55.71 | 55.90 | 61.36 | 89.06 | 121.12 | 34.96 | -61.75 | -140.99 | -140.99 | ||||||||||
| Taxes & Other Items | 9.62 | 20.81 | 20.17 | 13.84 | 24.02 | 31.26 | 9.39 | -14.81 | -6.24 | -6.24 | ||||||||||
| Net Income | 19.11 | 34.90 | 35.73 | 47.52 | 65.04 | 89.86 | 25.57 | -46.94 | -134.75 | -134.75 | ||||||||||
| EPS | 9.81 | 17.88 | 18.29 | 24.29 | 33.22 | 45.86 | 13.04 | -23.94 | -68.71 | -68.72 | ||||||||||
| DPS | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.15 | 0.08 | 0.08 | 0.06 | 0.05 | 0.03 | 0.11 | — | 0.00 | 0.00 |
ASTEC Company Updates
ASTEC Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
ASTEC Past Performance & Peer Comparison
ASTEC Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsFertilizers & Agro Chemicals
Compare valuation-basic on Screener
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Astec Lifesciences Ltd | -11.47 | 4.18 | — |
| Coromandel International Ltd | 32.65 | 7.14 | 0.65% |
| Fertilisers And Chemicals Travancore Ltd | 1,591.48 | 47.70 | 0.02% |
| UPL Ltd | 63.67 | 1.75 | 0.82% |
ASTEC Stock Price Comparison
Compare ASTEC with any stock or ETFCompare ASTEC with any stock or ETF
ASTEC
ASTEC Holdings
ASTEC Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
ASTEC Promoter Holdings Trend
ASTEC Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 4.13%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ASTEC Institutional Holdings Trend
ASTEC Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ASTEC Shareholding Pattern
ASTEC Shareholding Pattern
ASTEC Shareholding History
ASTEC Shareholding History
Foreign Institutions
Mutual Funds Invested in ASTEC
Mutual Funds Invested in ASTEC
No mutual funds holding trends are available
Top 5 Mutual Funds holding Astec Lifesciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4748% | Percentage of the fund’s portfolio invested in the stock 0.07% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 217/236 (-102) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7853% | Percentage of the fund’s portfolio invested in the stock 0.61% | Change in the portfolio weight of the stock over the last 3 months 0.61% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/54 (-23) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4888% | Percentage of the fund’s portfolio invested in the stock 0.28% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 39/58 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ASTEC stock
smallcases containing ASTEC stock
Looks like this stock is not in any smallcase yet.
ASTEC Events
ASTEC Events
ASTEC Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
ASTEC Dividend Trend
No dividend trend available
ASTEC Upcoming Dividends
ASTEC Upcoming Dividends
No upcoming dividends are available
ASTEC Past Dividends
ASTEC Past Dividends
Cash Dividend
Ex DateEx DateJul 19, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 19, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateJul 16, 2020
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 16, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateJul 19, 2018
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 19, 2018
ASTEC Stock News & Opinions
ASTEC Stock News & Opinions
Articles & Videos
Corporate
Astec Lifesciences AGM scheduled
Astec Lifesciences announced that the 31th Annual General Meeting(AGM) of the company will be held on 28 July 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Astec Life tumbles after Q4 net loss widens to Rs 16 cr
Revenue from operations declined 22.26% YoY to Rs 119.53 crore in the quarter ended 31 March 2025. Loss before tax stood at Rs 15.66 crore in Q4 FY25, widening from a loss of Rs 0.93 crore in the same period last year. EBITDA came in at Rs 6.32 crore in Q4 FY25, down 57.18% from Rs 14.76 crore reported in Q4 FY24. Total expense tanked 13.23% year on year to Rs 135.98 crore during the quarter. The cost of materials consumed was Rs 85.45 crore (up 3.58% YoY), while employee benefits expense stood at Rs 14.43 crore (down 1.77% YoY) during the period under review. On the margins front, operating margin narrowed to 4.62% in Q4 FY25, compared to 8.27% in Q4 FY24. N. B. Godrej, chairman of Astec LifeSciences, said, 'In Q4 FY25, Astec reported sequential improvement in performance. EBITDA for Q4 FY25 at Rs 6.8 crore showed an improvement over the earlier quarters. This positive trend was primarily due to an increase in volumes and prices in the enterprise business coupled with an improved product mix in the CDMO business. We expect an uptick in the demand for enterprise & CDMO businesses and a gradual improvement in the performance in the coming year.' Astec Lifesciences is into the manufacturing of agrochemical active ingredients (technical), bulk and formulations, and intermediate products, and it sells its products in India as well as exports them to approximately 24 countries.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 16.09 crore in the March 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 16.09 crore in the quarter ended March 2025 as against net loss of Rs 0.97 crore during the previous quarter ended March 2024. Sales declined 22.26% to Rs 119.53 crore in the quarter ended March 2025 as against Rs 153.75 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 134.75 crore in the year ended March 2025 as against net loss of Rs 46.93 crore during the previous year ended March 2024. Sales declined 16.78% to Rs 381.30 crore in the year ended March 2025 as against Rs 458.18 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales119.53153.75 -22 381.30458.18 -17 OPM %4.638.27 --17.36-1.29 - PBDT-4.088.08 PL -97.27-25.49 -282 PBT-15.66-0.93 -1584 -140.99-61.75 -128 NP-16.09-0.97 -1559 -134.75-46.93 -187 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Astec Lifesciences announces board meeting date
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 23 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 40.38 crore in the December 2024 quarter
Net Loss of Astec Lifesciences reported to Rs 40.38 crore in the quarter ended December 2024 as against net loss of Rs 24.33 crore during the previous quarter ended December 2023. Sales rose 84.80% to Rs 93.86 crore in the quarter ended December 2024 as against Rs 50.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.8650.79 85 OPM %-6.12-36.09 - PBDT-13.75-23.52 42 PBT-25.15-32.22 22 NP-40.38-24.33 -66 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Astec Lifesciences to table results
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Astec Lifesciences Ltd leads gainers in 'B' group
Avonmore Capital & Management Services Ltd, Spencers Retail Ltd, Jayaswal Neco Industries Ltd and Salasar Techno Engineering Ltd are among the other gainers in the BSE's 'B' group today, 03 January 2025.Astec Lifesciences Ltd spiked 20.00% to Rs 1164.75 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 11933 shares were traded on the counter so far as against the average daily volumes of 774 shares in the past one month. Avonmore Capital & Management Services Ltd surged 19.80% to Rs 23.42. The stock was the second biggest gainer in 'B' group. On the BSE, 33.56 lakh shares were traded on the counter so far as against the average daily volumes of 3.35 lakh shares in the past one month. Spencers Retail Ltd soared 14.31% to Rs 94.8. The stock was the third biggest gainer in 'B' group. On the BSE, 93122 shares were traded on the counter so far as against the average daily volumes of 15676 shares in the past one month. Jayaswal Neco Industries Ltd added 11.08% to Rs 44.42. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1.43 lakh shares were traded on the counter so far as against the average daily volumes of 25963 shares in the past one month. Salasar Techno Engineering Ltd gained 10.27% to Rs 14.07. The stock was the fifth biggest gainer in 'B' group. On the BSE, 35.53 lakh shares were traded on the counter so far as against the average daily volumes of 13.38 lakh shares in the past one month. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 38.56 crore in the September 2024 quarter
Net Loss of Astec Lifesciences reported to Rs 38.56 crore in the quarter ended September 2024 as against net loss of Rs 13.43 crore during the previous quarter ended September 2023. Sales declined 11.05% to Rs 98.55 crore in the quarter ended September 2024 as against Rs 110.79 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales98.55110.79 -11 OPM %-20.03-3.09 - PBDT-27.07-8.44 -221 PBT-38.54-17.60 -119 NP-38.56-13.43 -187 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Astec Lifesciences to hold board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Astec LifeSciences director resigns
Astec LifeSciences announced that Dr. Brahma Nand Vyas has tendered his resignation as an 'Independent Director' of the Company with effect from closure of business hours on 4 October 2024. Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 0.97%, vs industry avg of 10.4%
Over the last 5 years, market share decreased from 0.34% to 0.22%